Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
19 studies found for:    10655437 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Erlotinib;   Drug: Sorafenib
2 Withdrawn A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
Conditions: Ependymoma;   Brainstem Glioma;   Astrocytoma;   Glioblastoma Multiforme;   PNET
3 Active, not recruiting Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Sargramostim (GM-CSF, Leukine);   Drug: Flutamide (Eulexin);   Biological: PROSTVAC-F/ TRICOM;   Biological: PROSTVAC-V/TRICOM
4 Completed
Has Results
153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Samarium Sm 153 lexidronam pentasodium;   Biological: Sargramostim;   Biological: Recombinant vaccinia-TRICOM vaccine;   Biological: Recombinant fowlpox-TRICOM vaccine
5 Active, not recruiting TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization
6 Recruiting Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC
Condition: Hepatocellular Carcinoma
Interventions: Other: Embolization;   Other: Infusion of anticancer agent;   Other: Infusion of mixture of anticancer agent and lipiodol
7 Recruiting Asymptomatic Small Pancreatic Endocrine Neoplasms.
Condition: Non Functioning Pancreatic Endocrine Tumor
Interventions: Diagnostic Test: Radiological imaging studies;   Other: Quality of Life Assessment
8 Not yet recruiting Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26
Conditions: Carcinosarcoma, Ovarian;   Carcinosarcomas Uterine
Intervention: Drug: Trabectedin
9 Recruiting Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients _MITO-23
Condition: Ovarian Neoplasms
Interventions: Drug: Trabectedin;   Drug: Pegylated Liposomal Doxorubicin;   Drug: Topotecan;   Drug: Gemcitabine;   Drug: Weekly Paclitaxel;   Drug: Carboplatin
10 Unknown  Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient
Conditions: Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent;   No EGFR Activating Mutation
Interventions: Radiation: 18F-FLT-TEP;   Radiation: 18F-FDG-TEP
11 Recruiting European Low and Intermediate Risk Neuroblastoma Protocol
Intervention: Drug: chemotherapy
12 Unknown  Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)
Conditions: Sinonasal Malignancies:;   Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses
Intervention: Radiation: carbon ion boost
13 Recruiting Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy
Condition: Adenoid Cystic Carcinoma
Intervention: Drug: Cetuximab
14 Unknown  CO(Mbined Therapy of Malignant) S(Alivary Gland tu)M(Ours With)I(MRT and) c(Arbon Ions): COSMIC
Conditions: Malignancy;   Salivary Glands;   Tumor
Intervention: Radiation: carbon ion boost
15 Completed Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure
Condition: Soft Tissue Sarcoma
Intervention: Drug: LBH589 (Panobinostat®)
16 Completed
Has Results
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Bevacizumab
17 Active, not recruiting Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: paclitaxel;   Procedure: Surgery
18 Completed Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
Condition: Resistant Solid Malignancies
Interventions: Drug: Temsirolimus;   Drug: Docetaxel
19 Completed Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.
Condition: Breast Cancer
Interventions: Behavioral: Exercise Training;   Behavioral: Chemo only

Study has passed its completion date and status has not been verified in more than two years.